{
    "2019-06-22": [
        [
            {
                "time": "",
                "original_text": "二探“首家”科创药企微芯生物：单一产品遇内外伏兵，闯关前夜临定价难题",
                "features": {
                    "keywords": [
                        "微芯生物",
                        "科创板",
                        "单一产品",
                        "内外压力",
                        "定价难题"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}